← Leaderboards
John N Galgiani
Veterans Medical Research Fdn/San Diego
$10,827,556
Attributed
$13,840,893
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$17,959,360 · 9
By mechanism
P01$5,246,751 · 3
R01$4,819,617 · 1
RC3$2,999,834 · 1
U01$2,270,130 · 1
U54$1,594,308 · 1
R42$803,280 · 1
Top collaborators
- Steven M Holland4 shared
- Yves A Lussier4 shared
- David Larwood1 shared
Most similar at Veterans Medical Research Fdn/San Diego
Same institution · by research overlap
- David M. Rose$467,288
Others in their field
Top investigators on “Coccidioidomycosis”
- Susanna Naggie · Duke University$17,352,697
- Garry Thomas Cole · Veterans Medical Research Fdn/San Diego$5,455,899
- Justin V Remais · University Of California Berkeley$5,431,125
- Chiung-Yu Hung · University Of Texas San Antonio$5,101,104
- Bridget Marie Barker · University Of California, San Francisco$4,599,845
- Anita Sil · University Of California, San Francisco$4,260,384
Research focus
CoccidioidomycosisInfectionCoccidioidesPneumoniaLifeFutureLungBasePreventImmunologicsVaccine DevelopmentProgramsCytokineGenesMycosesClinical TrialsArizonaFungal AntigensVaccinationResponseResistanceSpecimenTissuesVaccines
Grant awards (32)
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis$1,149,998
R01 · FY2020 · AI · contact PI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$563,465
U01 · FY2020 · AI · contact PI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis$1,148,120
R01 · FY2019 · AI · contact PI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$579,122
U01 · FY2019 · AI · contact PI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis$1,150,297
R01 · FY2018 · AI · contact PI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$553,659
U01 · FY2018 · AI · contact PI
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis$1,371,202
R01 · FY2017 · AI · contact PI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$573,884
U01 · FY2017 · AI · contact PI
Coccidioides Proteins as Vaccine Antigens and Diagnostic Biosignatures$306,327
U54 · FY2013 · AI · contact PI
Coccidioides Proteins as Vaccine Antigens and Diagnostic Biosignatures$292,432
U54 · FY2012 · AI · contact PI
Coccidioides Proteins as Vaccine Antigens and Diagnostic Biosignatures$340,033
U54 · FY2011 · AI · contact PI
Nikkomycin Z treatment of early coccidioidal pneumonia: Phase II clinical trial$2,999,834
RC3 · FY2010 · MD · contact PI
Experimental Pharmacology and Chemical Studies of Nikkomycin Z$350,119
R42 · FY2010 · AI · contact PI
Coccidioides Proteins as Vaccine Antigens and Diagnostic Biosignatures$327,918
U54 · FY2010 · AI · contact PI
Experimental Pharmacology and Chemical Studies of Nikkomycin Z$350,567
R42 · FY2009 · AI · contact PI
Coccidioides Proteins as Vaccine Antigens and Diagnostic Biosignatures$327,598
U54 · FY2009 · AI · contact PI
Host control in Coccidioidomycosis$826,754
P01 · FY2008 · AI · contact PI
Histologic Markers of Resistance to Coccidioidomyoosis$107,005
P01 · FY2008 · AI · contact PI
Experimental Pharmacology and Chemical Studies of Nikkomycin Z$102,594
R42 · FY2008 · AI · contact PI
Host control in Coccidioidomycosis$818,219
P01 · FY2007 · AI · contact PI
Histologic Markers of Resistance to Coccidioidomyoosis$105,898
P01 · FY2007 · AI · contact PI
Host control in Coccidioidomycosis$817,883
P01 · FY2006 · AI · contact PI
Nikkomycin Z Treatment for Coccidioidomycosis$225,440
R34 · FY2006 · AI · contact PI
Histologic Markers of Resistance to Coccidioidomyoosis$108,401
P01 · FY2006 · AI · contact PI
Host control in Coccidioidomycosis$810,703
P01 · FY2005 · AI
Histologic Markers of Resistance to Coccidioidomyoosis$104,924
P01 · FY2005 · AI
Host control in Coccidioidomycosis$844,908
P01 · FY2004 · AI
Histologic Markers of Resistance to Coccidioidomyoosis$109,352
P01 · FY2004 · AI
IMMUNE RESPONSE TO COCCIDIOIDES IMMITIS PROLINE RICH ANTIGEN$157,141
P01 · FY2002 · AI
IMMUNE RESPONSE TO COCCIDIOIDES IMMITIS PROLINE RICH ANTIGEN$157,141
P01 · FY2001 · AI
IMMUNE RESPONSE TO COCCIDIOIDES IMMITIS PROLINE RICH ANTIGEN$157,141
P01 · FY2000 · AI
IMMUNE RESPONSE TO COCCIDIOIDES IMMITIS PROLINE RICH ANTIGEN$121,281
P01 · FY2000 · AI